Interleukin-17: A Promoter in Colorectal Cancer Progression-Reference-Cited by-同舟云学术

Interleukin-17: A Promoter in Colorectal Cancer Progression

Published:2013 Issue: Volume:2013 Page:1-7
ISSN:1740-2522
Container-title:Clinical and Developmental Immunology
language:en
Short-container-title:Clinical and Developmental Immunology

Author:

Wu Dang¹^ORCID,Wu Pin¹,Huang Qi¹,Liu Yang¹,Ye Jun¹^ORCID,Huang Jian¹^ORCID

Affiliation:

1. Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, China National Ministry of Education), Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009, China

Publisher

Hindawi Limited

Subject

General Medicine,Immunology,Immunology and Allergy

Link

http://downloads.hindawi.com/journals/jir/2013/436307.pdf

Reference61 articles.

1. Cancer-related inflammation

2. Immunity, Inflammation, and Cancer

3. Dual Roles for Immunity in Gastrointestinal Cancers

4. Cytokines, Inflammation and Colon Cancer

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Narciclasine induces colon carcinoma cell apoptosis by inhibiting the IL-17A/Act1/ TRAF6/NF-κB signaling pathway;GENES DIS;2024

2. Mucosal‐associated invariant T cells modulate innate immune cells and inhibit colon cancer growth;Scandinavian Journal of Immunology;2024-05-21

3. An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer;Frontiers in Immunology;2024-04-29

4. Characteristics of the Colorectal Cancer Microenvironment—Role in Cancer Progression and Therapeutic Possibilities;Applied Sciences;2024-03-30

5. Decreased interleukin‐17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice;Cancer Medicine;2024-03